The Centers for Medicare & Medicaid Services’ (CMS’) final rule advances policies to promote the efficient operation of the Medicaid Drug Rebate Program (MDRP).
Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program Final Rule
Newsroom Homepage
Listing of Newsroom articles
Fact Sheets
Short-Term, Limited-Duration Insurance; Independent, Noncoordinated Excepted Benefits Coverage; Level-Funded Plan Arrangements; and Tax Treatment of Certain Accident and Health Insurance (CMS-9904-P)
On July 7, 2023, the Department of Health and Human Services (HHS), the Department of Labor, and the Department of the Treasury (collectively, the Departments) released a notice of proposed rulemaking (NPRM). This NPRM proposes to modify the definition of short-term, limited-duration insurance Read more about Short-Term, Limited-Duration Insurance; Independent, Noncoordinated Excepted Benefits Coverage; Level-Funded Plan Arrangements; and Tax Treatment of Certain Accident and Health Insurance (CMS-9904-P)
Press Releases
HHS Announces Actions to Protect Consumers and Lower Health Care Costs
New Report Projects Nearly 19 Million Seniors Will Save $400 Per Year on Out-of-Pocket Prescription Drug Costs Read more about HHS Announces Actions to Protect Consumers and Lower Health Care Costs
Press Releases
Statement: Broader Medicare Coverage of Leqembi Available Following FDA Traditional Approval
Broader Medicare coverage is now available for Biogen and Eisai’s Leqembi (the brand name for lecanemab) following the Food and Drug Administration’s (FDA) move to grant traditional approval to the drug that treats individuals with Alzheimer’s disease. The Centers for Medicare & Medicaid Services Read more about Statement: Broader Medicare Coverage of Leqembi Available Following FDA Traditional Approval
Press Releases
CMS Releases Revised Guidance for Historic Medicare Drug Price Negotiation Program
For the first time, Medicare will negotiate prices directly with drug companies on behalf of people with Medicare, improving affordability for some of the costliest prescription drugs Read more about CMS Releases Revised Guidance for Historic Medicare Drug Price Negotiation Program
Fact Sheets
Calendar Year (CY) 2024 Home Health Prospective Payment System Proposed Rule (CMS-1780-P)
On June 30, 2023, the Centers for Medicare & Medicaid Services (CMS) issued the calendar year (CY) 2024 Home Health Prospective Payment System (HH PPS) Rate Update proposed rule, which would update Medicare payment policies and rates for Home Health Agencies (HHAs). This rule proposes a permanent Read more about Calendar Year (CY) 2024 Home Health Prospective Payment System Proposed Rule (CMS-1780-P)
Press Releases